论文部分内容阅读
Background and Purpose: Preclinical and clinical studies indicate that low dose glibenclamide exhibits pleiotropic protective effects by inhibiting the SUR1-TRPM4 channel in different CNS pathologies.Data in our laboratory showed that glibenclamide enhanced the efficacy of mild hypothermia both in vivo and in vitro.But the pharmacokinetics of low dose glibenclamide in rats with mild hypothermia is still unknown.